Chengdu Easton Biopharmaceuticals Co., Ltd. (688513.SS) SHH
61.50
-1.82(-2.87%)
Currency In CNY
- General
- Statistics
- Historical Data
- Profile
- Financials
61.50
-1.82(-2.87%)
Currency In CNY
Address
No.8, Xiyuan Avenue
Chengdu, 611731
China
Phone
86 28 6758 5121
Website
Sector
Healthcare
Industry
Biotechnology
Employees
1400
First IPO Date
September 02, 2020
| Name | Title | Pay | Year Born |
| Daming Zhang | Deputy GM & Director | 0 | 1973 |
| Xiao Qin Bo | Chief Financial Officer, Accounting Supervisor & Director | 0 | 1982 |
| Avinash Ramkisan Mane | Chief Scientist of Formulation Research Department & Core Technician | 0 | 1978 |
| Haibin Guo | Manager of Formulation Research Department & Core Technician | 0 | 1981 |
| Shuyun Li | Board Secretary | 0 | 1985 |
| Mingxu Yuan | GM & Director | 0 | 1972 |
| Xingyao Song | Deputy General Manager | 0 | 1977 |
| Zheng Pin Guan | Deputy GM & Core Technician | 0 | 1974 |
Chengdu Easton Biopharmaceuticals Co., Ltd. engages in the research, development, manufacture, and commercialization of pharmaceutical products. The company provides finished dosage forms in anesthetic/analgesics, cardiovascular, oncology, pediatrics, and other therapeutic fields. It also offers active pharmaceutical ingredients in oncology, cardiovascular, anesthetic/analgesics, anti-inflammatory, gastrointestinal, antiemetic, neurology/psychiatry , and urinary system therapeutic categories. The company was founded in 2009 and is based in Chengdu, China.